These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 3858272)

  • 21. [Experiences with determining carcinoembryonic antigen in tumors of the digestive tract].
    Pelikán A
    Zentralbl Chir; 1986; 111(18):1113-8. PubMed ID: 3024422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The clinical information value of an immunoenzyme study of the tumor markers CA-19-9, CEA and AFP in cancer of the stomach, pancreas, colon and rectum].
    Ial'chenko NA; Lagutin VD; Lavik NN; Musin II
    Vopr Onkol; 1991; 37(9-10):921-4. PubMed ID: 1726842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of the new tumor marker TAG-72.
    Guadagni F; Roselli M; Ferroni P; Amato T; Colcher D; Greiner JW; Schlom J
    Anticancer Res; 1991; 11(4):1389-94. PubMed ID: 1746895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ganglioside and carcinoembryonic antigens in the diagnosis of malignant tumors of the gastrointestinal tract].
    Ivanov PK; Samoĭlenko VM
    Vopr Onkol; 1984; 30(9):55-9. PubMed ID: 6495695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) in pancreatic cancer. Role of age and liver dysfunction.
    Del Favero G; Fabris C; Panucci A; Basso D; Plebani M; Baccaglini U; Leandro G; Burlina A; Naccarato R
    Bull Cancer; 1986; 73(3):251-5. PubMed ID: 3530354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [CA-50 in serum of patients with carcinoma. Clinical experiences with a new tumor marker].
    Bruhn HD; Broers H; Euler H; Everding A; Feller AC; Hedderich J; Jostarndt L; Jooss B; Zurborn KH; Löffler H
    Dtsch Med Wochenschr; 1986 Aug; 111(34):1267-72. PubMed ID: 3461933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis and treatment of colorectal cancer using monoclonal antibodies].
    Inagi H; Okuda H; Shimano T; Kadota T; Mori T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2291-7. PubMed ID: 3460528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Haglund C
    Anticancer Res; 2002; 22(4):2311-6. PubMed ID: 12174919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of serum pancreatic enzymes, carbohydrate antigen 19-9, and carcinoembryonic antigen in various pancreatic diseases.
    Satake K; Kanazawa G; Kho I; Chung Y; Umeyama K
    Am J Gastroenterol; 1985 Aug; 80(8):630-6. PubMed ID: 2411125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Carcinoembryonic antigen: diagnosis and tumor progression in gastrointestinal tumors].
    Brümmendorf T; Anderer FA; Staab HJ; Hornung A; Kieninger G
    Dtsch Med Wochenschr; 1985 Dec; 110(51-52):1963-8. PubMed ID: 4075992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
    Tappero G; Piantino P; Cerchier A; Pecchio F
    Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Utility of CA19-9 and CEA as tumor marker in colorectal cancer--comparison between serum level and distribution].
    Okuda K; Kodaira S; Watanabe M; Takami H; Teramoto T; Abe O; Iri H; Ino Y; Hirohashi S
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):969-77. PubMed ID: 3463631
    [No Abstract]   [Full Text] [Related]  

  • 33. The value of CA 19-9 in gastric and colorectal carcinoma.
    Safi F; Bittner R; Roscher R; Kübel R; Beger HG
    Cancer Invest; 1987; 5(5):401-7. PubMed ID: 3480768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of serum levels of carcinoembryonic antigen, CEA, and gastrointestinal cancer antigen, GICA or CA 19-9, for preoperative staging and postoperative monitoring of patients with colorectal carcinoma.
    Szymendera JJ; Nowacki MP; Kozłowicz-Gudzińska I; Kowalska M
    Dis Colon Rectum; 1985 Dec; 28(12):895-9. PubMed ID: 3864628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative study of the role of CA 19-9, CA 72-4 and CEA tumor antigens in the diagnosis of pancreatic cancer and other gastrointestinal malignant diseases].
    Czakó L; Takács T; Babarczy E; Dux L; Lonovics J
    Orv Hetil; 1997 Nov; 138(47):2981-5. PubMed ID: 9432648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis].
    Heptner G; Domschke S; Krapf F; Schneider MU; Iro H; Domschke W
    Dtsch Med Wochenschr; 1984 Aug; 109(35):1309-12. PubMed ID: 6590287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiparametric tumor marker (CA 19-9, CEA, AFP, POA) analyses of pancreatic juices and sera in pancreatic diseases.
    Schmiegel WH; Eberl W; Kreiker C; Kalthoff H; Bützow GH; Jessen K; Klapdor R; Soehendra N; Wargenau M; Classen M
    Hepatogastroenterology; 1985 Jun; 32(3):141-5. PubMed ID: 2410346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical value of the tumor markers CA 19/9 and carcinoembryonic antigen (CEA) in colorectal carcinomas: a critical comparison.
    von Kleist S
    Int J Biol Markers; 1986; 1(1):3-8. PubMed ID: 3480321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical evaluation of tumor markers in patients with colorectal cancer].
    Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N
    Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tumor markers in gastrointestinal cancer and its clinical significance].
    Taguchi T; Ota J; Sumida S; Rii M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3004-9. PubMed ID: 3479051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.